Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;88:578-586

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwata, M.
Right arrow Articles by Ogawa, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwata, M.
Right arrow Articles by Ogawa, S.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Heart failure - basic studies
Right arrow Myocardial cardiomyopathy disease
(Circulation Research. 2001;88:578.)
© 2001 American Heart Association, Inc.


Integrative Physiology

Autoimmunity Against the Second Extracellular Loop of ß1-Adrenergic Receptors Induces ß-Adrenergic Receptor Desensitization and Myocardial Hypertrophy In Vivo

Michikado Iwata, Tsutomu Yoshikawa, Akiyasu Baba, Toshihisa Anzai, Iwao Nakamura, Yumiko Wainai, Toshiyuki Takahashi, Satoshi Ogawa

From the Cardiology Division, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Correspondence to Tsutomu Yoshikawa, MD, Cardiology Division, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan 160-8582. E-mail tyoshi{at}mc.med.keio.ac.jp

Abstract—Although immunoapheresis removing autoantibodies against the second extracellular domain of ß1-adrenergic receptors (ARs) improves cardiac function in patients with cardiomyopathy, the underlying mechanisms have not been defined. We examined the role of autoimmunity against the domain in the development of cardiac dysfunction in vivo. Japanese white rabbits were immunized with a synthetic peptide corresponding to the second extracellular loop of ß1-AR once a month with (ß+biso rabbits, n=10) or without (ß rabbits, n=13) bisoprolol treatment (2 mg/kg per day). Control rabbits received vehicle without bisoprolol treatment (n=13). Autoantibodies of IgG isotype against the domain were persistently detected in ß and ß+biso rabbits. Purified IgG from sera of ß and ß+biso rabbits increased cAMP production in a rabbit cardiac membrane preparation, which was blocked by bisoprolol. At 3 months, ß-AR uncoupling with increased G protein–coupled receptor kinase 5 (GRK5) expression was found in ß rabbits. At 6 months, left ventricular hypertrophy was noted with hemodynamic derangements in ß rabbits. This was accompanied by decreased ß1-AR density and increased inhibitory G protein and GRK5 expression, which were related to marked decrease in membrane cAMP production. These changes in ß rabbits at 6 months were prevented in ß+biso rabbits. There was no difference in the plasma norepinephrine concentration in the 3 groups over the observation period. Thus, autoimmunity against the second extracellular loop of ß1-ARs induced profound ß-AR desensitization and myocardial hypertrophy in vivo, associated with cardiac dysfunction. Sustained sympathomimetic-like actions of autoantibodies against the domain may be partly responsible for these changes.


Key Words: autoimmunity • cardiomyopathy • ß-adrenergic receptor • hypertrophy • cardiac dysfunction




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Mao, S. Fukuoka, C. Iwai, J. Liu, V. K. Sharma, S.-S. Sheu, M. Fu, and C.-s. Liang
Cardiomyocyte apoptosis in autoimmune cardiomyopathy: mediated via endoplasmic reticulum stress and exaggerated by norepinephrine
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1636 - H1645.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Fukuda, S. Miyoshi, K. Tanimoto, K. Oota, K. Fujikura, M. Iwata, A. Baba, Y. Hagiwara, T. Yoshikawa, H. Mitamura, et al.
Autoimmunity against the second extracellular loop of beta1-adrenergic receptors induces early afterdepolarization and decreases in K-channel density in rabbits
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1090 - 1100.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. Wallukat, J. Muller, and R. Hetzer
Specific Removal of {beta}1-Adrenergic Autoantibodies from Patients with Idiopathic Dilated Cardiomyopathy
N. Engl. J. Med., November 28, 2002; 347(22): 1806 - 1806.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H.-R. Liu, R.-R. Zhao, X.-Y. Jiao, Y.-Y. Wang, and M. Fu
Relationship of myocardial remodeling to the genesis of serum autoantibodies to cardiac beta1-adrenoceptors and muscarinic type 2 acetylcholine receptors in rats
J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1866 - 1873.
[Abstract] [Full Text] [PDF]